Late effects: Insights into Cardiovascular disease risk after Hodgkin's lymphoma Treatment

Late effects: Insights into Cardiovascular disease risk after Hodgkin's lymphoma Treatment - LICHT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35871

Enrollment

2000

Registered

2011-07-14

Start date

2011-09-01

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases heart disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 5 year Hodkin's Lymphoma survivors - treated in the Netherlands between 1965 and 2005

Exclusion criteria

Exclusion criteria: - None

Design outcomes

Primary

Measure	Time frame
Primary outcomes are: - Myocardial infarction - Angina Pectoris - Valvular disease - Chronic Heart Failure	—

Countries

Netherlands

Outcome results